6 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp03600 | l3,10,13K7,8K4R2L9 | KLlRLLkkLlRLlLK | Diastereomeric peptide | Plasma membrane perturbation; Necrosis | XTT assay | B16-F10 | Skin cancer | LC50 : 2.5 µM |
| dbacp03601 | l3,10,13K7,8K4R2L9 | KLlRLLkkLlRLlLK | Diastereomeric peptide | Plasma membrane perturbation; Necrosis | XTT assay | D-122 | Lung cancer | LC50 : 4.5 µM |
| dbacp03602 | l3,4,8,10K5L7 | KlllKLKlKlLK | Diastereomeric peptide | Plasma membrane perturbation; Necrosis | XTT assay | B16-F10 | Skin cancer | LC50 : 100 µM |
| dbacp03603 | l3,4,8,10K5L7 | KLllKLKlKlLK | Diastereomeric peptide | Plasma membrane perturbation; Necrosis | XTT assay | D-122 | Lung cancer | LC50 : >50 µM |
| dbacp07877 | Fi-Histin1-21 | SRSSRAGLQFPVGRIHRLLRK | Fenneropenaeus indicus | Membrane disruption and DNA binding | XTT assay | NCI-H-460 | Lung Cancer | IC50 = 22.670 ± 13.939 μM |
| dbacp07878 | Fi-Histin1-21 | SRSSRAGLQFPVGRIHRLLRK | Fenneropenaeus indicus | Membrane disruption and DNA binding | XTT assay | Hep-2 | Liver Cancer | IC50 = 31.274 ± 24.531 μM |